Issue 23 | 2015
Get instant access to latest e-book

latest news


Nov 2015

Lannett completes acquisition of Kremers Urban Pharmaceuticals for $1.23 Billion

Lannett Company Inc announced that it has completed the acquisition of Kremers Urban Pharmaceuticals Inc KU the US specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB SA Euronext UCB Lannett has acquired KU from UCB for total consideration of approximatel..


Nov 2015

Merck KGaA said to weigh Allergy Therapy Unit sale to Trim Debt

Merck KGaA is considering a sale of its allergy business as the German company seeks to reduce debt following the billion takeover of SigmaAldrich Corp according to people with knowledge of the matter The business known as Allergopharma may fetch about million euros million and could attract interest from drug companies and privateequity firms ..


Nov 2015

French pharmaceutical firm Servier plans to cut 610 jobs

Privatelyowned French pharmaceutical company Servier said on Thursday it planned to cut jobs and would reorganise its sales network due to competitive pressures and a tougher regulatory environment The firm said it had been penalised by patent losses a rapid growth in generic drugs regulated prices and delays in obta..


Nov 2015

India's Alkem plans to double U.S. revenue by 2020, launch IPO in Dec

Alkem Laboratories Ltd on Wednesday said it expects the contribution of the US sales as a share of overall revenue to double in the next five years just as it has doubled in the last five years International revenue which was just of the overall revenue in rose to by the company management said The US accounts for..

events

01 - 02

Dec 2015

01 - 02

Dec 2015


Eurasanté and Nutrition Health and Longevity cluster
Strasbourg, France


Nov 2015

CPhI and P-MEC India 2015 to create regional knowledge and business hub

CPhI and PMEC India cphiindia pmecindia organised ..


Nov 2015


  • 2

    Pricing Pharmaceuticals in India

    The issue of striking an optimum level of drug pricing so as to favor both the customers as well as the producers has been one of the most volatile subjects at ..

knowledge bank

  • interviews

    ExpreS2ion Biotechnologies

    Vice President - Business Development
    ExpreS2ion Biotechnologies’ protein expression system ExpreS2 is an important protein expression tool in the scientist’s tool box for protein expression. The ExpreS2 platform has demonstrated i..

  • Articles

    Better ways to handle tablets using IBCs

    Still handling tablets in drums It is common to find Intermediate Bulk Containers IBCs being used for handling powders and granules in solid dosage manufacturing processes from initial Dispensing through to Tablet Compression or Capsule Filling The benefits of using IBCs for efficient and flexible materials handling at this stage of the process are widely appreciated and applied in modern facilit..

  • Research Insights

    Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

    Abstract In December of chikungunya virus CHIKV an alphavirus in the family Togaviridae was introduced to the island of Saint Martin in the Caribbean resulting in the first autochthonous cases reported in the Americas As of January local and imported CHIKV has been reported in American countries with over million suspected cases CHIKV causes a severe arthralgic disease for which there are no approved vaccines or therapeutics Furthermore the ..

  • Case Studies

    Isolation Technology: Case Study

    A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying process The following requirements had to be met bullTo provide a safe barrier between the operator and the active drug substance to provide both operator an..

editorial Section

  • Strategy


    The bioprinting of tissues and organs has been big news recently However the patenting of bioprinting techniques has quietly been going on for years This article will discuss the patents covering the three process phases of bioprinting the exceptions to patent infringement for experimental uses and the prospects for further patenting and patent infringement lawsuits..

  • Research Developement

    Rethinking Drug Discovery

    The quest to undertake biological targets that are based on the regulation of signalling pathways is challenging the classical thinking in the drug discovery arena Historically the complexity of the biological system was underestimated It is now wellaccepted that compared to old biological targets that were focused on single gene or gene products w..

  • Clinical Trails

    Issues & Concerns in Conducting Clinical Trials in India

    Issues like approval delays deficiencies of functioning of CROs and other stake holders liabilities and compensation to injured subjects insurance issues etc still remain in India which has made multinational companies to rethink on opting for India to conduct clinical trials in India recently There is a need for a law to ensure that the people who undergo clinical trials are not exploited and should be well informed about risk as well to provide..

  • Manufacturing

    Validation Projects in China

    This article is a firsthand account of the experiences of Pharmadule in guiding leading Chinese manufacturers through facility investment projects aimed at compliance with Chinese US and EU GMP requirements These manufacturers have been among the first in the world to fully embrace the work procedures outlined in ICH Q Q and Q Implementing these guidelines in large organisations would be a challen..

  • Information Technology

    Quality by Design

    The article presents a novel approach to applying Quality by Design QbD principles to the development of analytical methods Common critical parameters in HPLC gradient time temperature pH of the aqueous eluent and stationary phase are evaluated within the Quality by Design framework It is useful for the robust analytical method development and Design Space optimisation..

  • Expert Talk

    Peptides Remain a Growth Story

    Cloud solutions offer immediate returns in improving operational performance and reducing costs Multiple approaches to cloud solutions will be needed to satisfy life science industry needs complicating the development of a coherent cloud strategy..